Ana Lucrecia Woodward

Array ( [id] => 5794267 [patent_doc_number] => 20060014948 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-19 [patent_title] => 'Piperazine derivatives' [patent_app_type] => utility [patent_app_number] => 10/968473 [patent_app_country] => US [patent_app_date] => 2004-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 63616 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20060014948.pdf [firstpage_image] =>[orig_patent_app_number] => 10968473 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6991485 [patent_doc_number] => 20050090522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-28 [patent_title] => 'Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives' [patent_app_type] => utility [patent_app_number] => 10/969675 [patent_app_country] => US [patent_app_date] => 2004-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 99582 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20050090522.pdf [firstpage_image] =>[orig_patent_app_number] => 10969675 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5259706 [patent_doc_number] => 20070213338 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Triazolo-Pyridazine Compounds and Derivatives Thereof Useful in the Treatment of Neuropathic Pain' [patent_app_type] => utility [patent_app_number] => 10/575942 [patent_app_country] => US [patent_app_date] => 2004-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29823 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213338.pdf [firstpage_image] =>[orig_patent_app_number] => 10575942 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4977983 [patent_doc_number] => 20070219216 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-20 [patent_title] => '1-Alkylpiperazinyl-Pyrrolidin-2,5-Dione Derivatives as Adrenergic Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 10/575606 [patent_app_country] => US [patent_app_date] => 2004-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18885 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0219/20070219216.pdf [firstpage_image] =>[orig_patent_app_number] => 10575606 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7105305 [patent_doc_number] => 20050107389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-19 [patent_title] => 'Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands' [patent_app_type] => utility [patent_app_number] => 10/960399 [patent_app_country] => US [patent_app_date] => 2004-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 42185 [patent_no_of_claims] => 73 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0107/20050107389.pdf [firstpage_image] =>[orig_patent_app_number] => 10960399 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5051959 [patent_doc_number] => 20070032504 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-02-08 [patent_title] => 'Polymorphic form of 3-phenylsulfonyl -8-piperazin-1-yl-quinoline' [patent_app_type] => utility [patent_app_number] => 10/572670 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 3746 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20070032504.pdf [firstpage_image] =>[orig_patent_app_number] => 10572670 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 588151 [patent_doc_number] => 07439243 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Piperazinyl-quinoline derivatives useful for the treatment of CNS disorders' [patent_app_type] => utility [patent_app_number] => 10/572671 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6263 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/439/07439243.pdf [firstpage_image] =>[orig_patent_app_number] => 10572671 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7206875 [patent_doc_number] => 20050043320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-24 [patent_title] => 'Benzoylguanidine salt and hydrates thereof' [patent_app_type] => utility [patent_app_number] => 10/948827 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2113 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20050043320.pdf [firstpage_image] =>[orig_patent_app_number] => 10948827 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 745125 [patent_doc_number] => 07026323 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-11 [patent_title] => 'Platelet adenosine diphosphate receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/947579 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65857 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/026/07026323.pdf [firstpage_image] =>[orig_patent_app_number] => 10947579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7011447 [patent_doc_number] => 20050065163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Platelet adenosine diphosphate receptor antagonists' [patent_app_type] => utility [patent_app_number] => 10/947635 [patent_app_country] => US [patent_app_date] => 2004-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 65833 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065163.pdf [firstpage_image] =>[orig_patent_app_number] => 10947635 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6918762 [patent_doc_number] => 20050096323 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Diketopiperazine derivatives to inhibit thrombin' [patent_app_type] => utility [patent_app_number] => 10/937574 [patent_app_country] => US [patent_app_date] => 2004-09-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12734 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096323.pdf [firstpage_image] =>[orig_patent_app_number] => 10937574 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 588154 [patent_doc_number] => 07439244 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-21 [patent_title] => 'Quinoline compounds and pharmeceutical compositions containing them' [patent_app_type] => utility [patent_app_number] => 10/571405 [patent_app_country] => US [patent_app_date] => 2004-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8945 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/439/07439244.pdf [firstpage_image] =>[orig_patent_app_number] => 10571405 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 798025 [patent_doc_number] => 07427612 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-23 [patent_title] => 'Benzoyl-piperazine derivatives' [patent_app_type] => utility [patent_app_number] => 10/933103 [patent_app_country] => US [patent_app_date] => 2004-09-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37482 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/427/07427612.pdf [firstpage_image] =>[orig_patent_app_number] => 10933103 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 569621 [patent_doc_number] => 07462617 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-09 [patent_title] => 'Substituted acylpiperazine derivatives' [patent_app_type] => utility [patent_app_number] => 10/933072 [patent_app_country] => US [patent_app_date] => 2004-09-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 21099 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/462/07462617.pdf [firstpage_image] =>[orig_patent_app_number] => 10933072 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4960615 [patent_doc_number] => 20080275040 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => '8-(1-Piperazinyl)-Quinoline Derivatives and Their Use in the Treatment of Cns Disorders' [patent_app_type] => utility [patent_app_number] => 10/570002 [patent_app_country] => US [patent_app_date] => 2004-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6957 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275040.pdf [firstpage_image] =>[orig_patent_app_number] => 10570002 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7609786 [patent_doc_number] => 06998403 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-14 [patent_title] => 'Benzoindoline compounds' [patent_app_type] => utility [patent_app_number] => 10/925712 [patent_app_country] => US [patent_app_date] => 2004-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5185 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 153 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/998/06998403.pdf [firstpage_image] =>[orig_patent_app_number] => 10925712 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5643303 [patent_doc_number] => 20060281758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-14 [patent_title] => 'Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine' [patent_app_type] => utility [patent_app_number] => 10/568292 [patent_app_country] => US [patent_app_date] => 2004-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9546 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0281/20060281758.pdf [firstpage_image] =>[orig_patent_app_number] => 10568292 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7622200 [patent_doc_number] => 06977301 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-12-20 [patent_title] => 'Process for preparing (S) and (R)—2-[4-(4-chlorobenzhydryl)piperazin-1-yl]-ethoxyacetamide' [patent_app_type] => utility [patent_app_number] => 10/920434 [patent_app_country] => US [patent_app_date] => 2004-08-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4531 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/977/06977301.pdf [firstpage_image] =>[orig_patent_app_number] => 10920434 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7180817 [patent_doc_number] => 20050124604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-09 [patent_title] => 'Substituted naphthyridine derivatives as inhibitors of macrophage migration inhibitory factor and their use in the treatment of human diseases' [patent_app_type] => utility [patent_app_number] => 10/920031 [patent_app_country] => US [patent_app_date] => 2004-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55936 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20050124604.pdf [firstpage_image] =>[orig_patent_app_number] => 10920031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6959376 [patent_doc_number] => 20050215526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Melanin concentrating hormone receptor antagonist' [patent_app_type] => utility [patent_app_number] => 10/916011 [patent_app_country] => US [patent_app_date] => 2004-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55345 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215526.pdf [firstpage_image] =>[orig_patent_app_number] => 10916011 [rel_patent_id] =>[rel_patent_doc_number] =>)